269 related articles for article (PubMed ID: 21461220)
1. Factors influencing the visual acuity of chronic central serous chorioretinopathy.
Kim YY; Flaxel CJ
Korean J Ophthalmol; 2011 Apr; 25(2):90-7. PubMed ID: 21461220
[TBL] [Abstract][Full Text] [Related]
2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
3. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study.
Bae S; Jin K; Kim H; Bae SH
BMC Ophthalmol; 2015 Dec; 15():180. PubMed ID: 26677843
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
5. Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy.
Ojima Y; Tsujikawa A; Yamashiro K; Ooto S; Tamura H; Yoshimura N
Jpn J Ophthalmol; 2010 Jan; 54(1):55-60. PubMed ID: 20151277
[TBL] [Abstract][Full Text] [Related]
6. Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.
Iacono P; Battaglia PM; Papayannis A; La Spina C; Varano M; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1889-97. PubMed ID: 25563727
[TBL] [Abstract][Full Text] [Related]
7. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
8. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.
Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK
JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386
[TBL] [Abstract][Full Text] [Related]
9. Fundus autofluorescence findings in central serous chorioretinopathy using two different confocal scanning laser ophthalmoscopes: correlation with functional and structural status.
Shin JY; Choi HJ; Lee J; Choi M; Chung B; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1537-1544. PubMed ID: 26690973
[TBL] [Abstract][Full Text] [Related]
10. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
[TBL] [Abstract][Full Text] [Related]
11. [OCT-morphometric and angiographic parallels between different variants of central serous chorioretinopathy].
Panova IE; Shaimov TB; Shaimova VA
Vestn Oftalmol; 2017; 133(2):10-17. PubMed ID: 28524134
[TBL] [Abstract][Full Text] [Related]
12. Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
Vasconcelos H; Marques I; Santos AR; Melo P; Pires I; Figueira J; de Abreu JF; Cachulo ML; Silva R
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1697-705. PubMed ID: 23389551
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
14. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Song JH; Park A; Kim MH
Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.
Sahoo NK; Mishra SB; Iovino C; Singh SR; Munk MR; Berger L; Peiretti E; Chhablani J
Br J Ophthalmol; 2019 Nov; 103(11):1615-1618. PubMed ID: 30602447
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography angiography versus fluorescein angiography in diagnosing choroidal neovascularization in chronic central serous chorioretinopathy.
Bansal R; Dogra M; Mulkutkar S; Katoch D; Singh R; Gupta V; Dogra MR; Gupta A
Indian J Ophthalmol; 2019 Jul; 67(7):1095-1100. PubMed ID: 31238419
[TBL] [Abstract][Full Text] [Related]
17. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
[TBL] [Abstract][Full Text] [Related]
18. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
19. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.
Lim JI; Glassman AR; Aiello LP; Chakravarthy U; Flaxel CJ; Spaide RF;
Ophthalmology; 2014 May; 121(5):1073-8. PubMed ID: 24439758
[TBL] [Abstract][Full Text] [Related]
20. Central serous chorioretinopathy and achromatopsia: a case report.
Mahmoudi A; Berijani S; Bazvand F; Adelpour F; Khojasteh H
Doc Ophthalmol; 2020 Dec; 141(3):307-312. PubMed ID: 32424630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
